Literature DB >> 22205709

In vitro studies of novel PRKAR1A mutants that extend the predicted RIα protein sequence into the 3'-untranslated open reading frame: proteasomal degradation leads to RIα haploinsufficiency and Carney complex.

Yianna Patronas1, Anelia Horvath, Elizabeth Greene, Kitman Tsang, Eirini Bimpaki, Michelle Haran, Maria Nesterova, Constantine A Stratakis.   

Abstract

BACKGROUND: Carney complex (CNC) is a multiple endocrine neoplasia syndrome due to inactivating mutations in the PRKAR1A gene that codes for type Iα regulatory (RIα) subunit of protein kinase A. Most PRKAR1A mutations are subject to nonsense mRNA decay (NMD) and, thus, lead to haploinsufficiency. METHODS AND
SETTING: Patient phenotyping for CNC features and DNA, RNA, protein, and transfection studies were carried out at a research center.
RESULTS: We describe in unrelated kindreds with CNC four naturally occurring PRKAR1A mutations (1055del4, 1067del4ins5, 1076delTTins13, and 1142del4) that are predicted to escape NMD because they are located in the last coding exon of the gene. The phenotype of CNC was not different from that in other patients with the condition, although the number of patients was small. Each of the mutations caused a frameshift that led to a new stop codon into the 3' untranslated open reading frame, predicting an elongated protein that, however, was absent in patient-derived cells. After site-directed mutagenesis, in vitro transcription, and cell-free translation experiments, the expected size mutant proteins were present. However, when the mutant constructs were transfected in adrenal (NCI-295), testicular (N-TERA), and embryonic (HEK293) cells and despite the presence of the mutant mRNA, Western blot analysis indicated that there were no longer proteins. The subsequent application of proteasome inhibitors to cells transfected with the mutant constructs led to the detection of the aberrant proteins, although a compound that affects protein folding had no effect. The wild-type protein was also decreased in both patient-derived cells and/or tissues as well as in the in vitro systems used in this study.
CONCLUSIONS: This was the first demonstration of proteasomal degradation of RIα protein variants leading to PRKAR1A haploinsufficiency and CNC, adding protein surveillance to NMD in the cellular mechanisms overseeing RIα synthesis. In agreement with the molecular data, CNC patients bearing PRKAR1A defects that extend the open reading frame did not have a different phenotype, although this has to be confirmed in a larger number of patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22205709      PMCID: PMC3319211          DOI: 10.1210/jc.2011-2220

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

1.  Aberrant mRNAs with extended 3' UTRs are substrates for rapid degradation by mRNA surveillance.

Authors:  D Muhlrad; R Parker
Journal:  RNA       Date:  1999-10       Impact factor: 4.942

Review 2.  The ubiquitin-proteasome pathway and proteasome inhibitors.

Authors:  J Myung; K B Kim; C M Crews
Journal:  Med Res Rev       Date:  2001-07       Impact factor: 12.944

3.  Translation of aberrant mRNAs lacking a termination codon or with a shortened 3'-UTR is repressed after initiation in yeast.

Authors:  Toshifumi Inada; Hiroji Aiba
Journal:  EMBO J       Date:  2005-03-31       Impact factor: 11.598

4.  Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex.

Authors:  L S Kirschner; J A Carney; S D Pack; S E Taymans; C Giatzakis; Y S Cho; Y S Cho-Chung; C A Stratakis
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

5.  Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex.

Authors:  L S Kirschner; F Sandrini; J Monbo; J P Lin; J A Carney; C A Stratakis
Journal:  Hum Mol Genet       Date:  2000-12-12       Impact factor: 6.150

Review 6.  Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation.

Authors:  C A Stratakis; L S Kirschner; J A Carney
Journal:  J Clin Endocrinol Metab       Date:  2001-09       Impact factor: 5.958

7.  Proteasomal degradation of unassembled mutant type I collagen pro-alpha1(I) chains.

Authors:  J Fitzgerald; S R Lamandé; J F Bateman
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

Review 8.  Minireview: PRKAR1A: normal and abnormal functions.

Authors:  Ioannis Bossis; Constantine A Stratakis
Journal:  Endocrinology       Date:  2004-08-26       Impact factor: 4.736

9.  Dominant inheritance of the complex of myxomas, spotty pigmentation, and endocrine overactivity.

Authors:  J A Carney; L S Hruska; G D Beauchamp; H Gordon
Journal:  Mayo Clin Proc       Date:  1986-03       Impact factor: 7.616

10.  The structural domains of cAMP-dependent protein kinase I. Characterization of two sites of proteolytic cleavage and homologies to cAMP-dependent protein kinase II.

Authors:  R L Potter; S S Taylor
Journal:  J Biol Chem       Date:  1980-10-25       Impact factor: 5.157

View more
  7 in total

Review 1.  Carney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics.

Authors:  Paraskevi Salpea; Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2013-09-05       Impact factor: 4.102

Review 2.  Carney complex: an update.

Authors:  Ricardo Correa; Paraskevi Salpea; Constantine A Stratakis
Journal:  Eur J Endocrinol       Date:  2015-06-30       Impact factor: 6.664

3.  Loss-of-Function Mutations in ELMO2 Cause Intraosseous Vascular Malformation by Impeding RAC1 Signaling.

Authors:  Arda Cetinkaya; Jingwei Rachel Xiong; İbrahim Vargel; Kemal Kösemehmetoğlu; Halil İbrahim Canter; Ömer Faruk Gerdan; Nicola Longo; Ahmad Alzahrani; Mireia Perez Camps; Ekim Zihni Taskiran; Simone Laupheimer; Lorenzo D Botto; Eeswari Paramalingam; Zeliha Gormez; Elif Uz; Bayram Yuksel; Şevket Ruacan; Mahmut Şamil Sağıroğlu; Tokiharu Takahashi; Bruno Reversade; Nurten Ayse Akarsu
Journal:  Am J Hum Genet       Date:  2016-07-28       Impact factor: 11.025

Review 4.  cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse.

Authors:  Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2013-02-26       Impact factor: 4.102

5.  Corticotropinoma as a Component of Carney Complex.

Authors:  Laura C Hernández-Ramírez; Christina Tatsi; Maya B Lodish; Fabio R Faucz; Nathan Pankratz; Prashant Chittiboina; John Lane; Denise M Kay; Nuria Valdés; Aggeliki Dimopoulos; James L Mills; Constantine A Stratakis
Journal:  J Endocr Soc       Date:  2017-05-30

6.  PRKACB variants in skeletal disease or adrenocortical hyperplasia: effects on protein kinase A.

Authors:  Stephanie Espiard; Ludivine Drougat; Nikolaos Settas; Sara Haydar; Kerstin Bathon; Edra London; Isaac Levy; Fabio R Faucz; Davide Calebiro; Jérôme Bertherat; Dong Li; Michael A Levine; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2020-11       Impact factor: 5.678

7.  Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With Missense AIP Mutations.

Authors:  Laura C Hernández-Ramírez; Federico Martucci; Rhodri M L Morgan; Giampaolo Trivellin; Daniel Tilley; Nancy Ramos-Guajardo; Donato Iacovazzo; Fulvio D'Acquisto; Chrisostomos Prodromou; Márta Korbonits
Journal:  J Clin Endocrinol Metab       Date:  2016-06-02       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.